Miltiades P, Lamprianidou E, Kerzeli I, Nakou E, Papamichos S, Spanoudakis E, et al. Three-fold higher frequency of circulating chronic lymphocytic leukemia-like B-cell clones in patients with Ph-Myeloproliferative neoplasms. Leuk Res. 2015;: pubmed publisher

Poirot L, Philip B, Schiffer Mannioui C, Le Clerre D, Chion Sotinel I, Derniame S, et al. Multiplex Genome-Edited T-cell Manufacturing Platform for "Off-the-Shelf" Adoptive T-cell Immunotherapies. Cancer Res. 2015;75:3853-64 pubmed publisher

Smeltzer J, Jones J, Ziesmer S, Grote D, Xiu B, Ristow K, et al. Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphoma. Clin Cancer Res. 2014;20:2862-72 pubmed publisher

Grada Z, Hegde M, Byrd T, Shaffer D, Ghazi A, Brawley V, et al. TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy. Mol Ther Nucleic Acids. 2013;2:e105 pubmed publisher

Horton H, Bernett M, Pong E, Peipp M, Karki S, Chu S, et al. Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia. Cancer Res. 2008;68:8049-57 pubmed publisher

Rosa D, Saletti G, De Gregorio E, Zorat F, Comar C, D Oro U, et al. Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc Natl Acad Sci U S A. 2005;102:18544-9 pubmed